Rebranding Repurposing: a Polypharmacological Perspective
“Drug repurposing doesn’t work. We’ve all tried it and it doesn’t work.”
Posts about
Drug Discovery
How Cyclica's Innovation fuels our success and continuous drive to tackle low data targets
Over the years, many aspects of Cyclica’s business and technology have changed, sometimes...
Drug Discovery on the Dark Proteome - Delivering Tomorrow's Medicines
The role of a given protein(s) to a specific disease or indication is a fundamental aspect of drug...
The need for speed: how drug target discovery can drive change in precision medicine
Employee Perspective: Cyclica’s Marketing and Communications Specialist, Rebecca Woelfle
Response to Scripps Research Institute Paper on DCAF-1
A vast majority of protein targets in the human proteome have been deemed undruggable given the...
AI is not the Silver Bullet
As innovators, entrepreneurs, and operators, we have a responsibility to ensure that our...
Artificial Intelligence in Drug Discovery
Artificial Intelligence (AI) systems, specifically machine learning (ML) technologies, learn how to...
AlphaFold 2: What No One Is Talking About
In this next installment of our AlphaFold Series, we look at the potential drawbacks and...
Cyclica successfully integrates DeepMind’s AlphaFold 2
AlphaFold 2 has provided structures for a large percentage of the proteome, perfectly complementary...
Full Speed Ahead: What DeepMind’s Newest Revelation means for Scientific/Research Advancement
Last Week, DeepMind announced on their blog that they had made available, in collaboration with...